Traws Pharma, Inc.
8-K
February 19, 2026
Key Highlights
- Ratutrelvir (COVID-19 drug) shows positive Phase 2 results with significantly fe...
- Ratutrelvir offers faster symptom resolution for PAXLOVID®-ineligible patients, ...
- Traws Pharma is advancing Ratutrelvir to pivotal Phase 3 trials and NDA submissi...
Read Analysis
🤖 AI Generated